Drugs that contain Metoclopramide Hydrochloride

1. List of Gimoti drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11020361 EVOKE PHARMA INC Nasal formulations of metoclopramide
Dec, 2029

(6 years from now)

US8334281 EVOKE PHARMA INC Nasal formulations of metoclopramide
May, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Jun 19, 2023

Market Authorisation Date: 19 June, 2020

Treatment: Nasal administration of metoclopramide for treatment of diabetic gastroparesis

Dosage: SPRAY, METERED;NASAL

How can I launch a generic of GIMOTI before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic